Turn Therapeutics Inc.: updates and filings

TTRXNASDAQHealthcare · Pharmaceutical Preparations

Price

$8.10

November 20, 2026Market cap $241M

What Ploutos Investor adds for Turn Therapeutics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 2 fiscal years, from 2024
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Mar 31, 2026 latest annualNov 9, 2026 latest quarterly
  • Nov 16, 2026Filing
    FormEFFECT
  • Nov 16, 2026Filing
    FormEFFECT
  • Nov 10, 2026Regulation FD disclosure
    Form8-K
  • Nov 9, 2026Shelf registration for future offerings
    FormS-3
  • Nov 9, 2026Shelf registration for future offerings
    FormS-3
  • Nov 9, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Nov 9, 2026Results of operations
    Form8-K
  • Oct 19, 2026Annual report to shareholdersfor the period to Dec 31, 2025
    FormARS
  • Oct 19, 2026Annual meeting proxy statement
    FormDEF 14A
  • Oct 7, 2026Regulation FD disclosure
    Form8-K
  • Sep 10, 2026Regulation FD disclosure
    Form8-K
  • Sep 9, 2026Regulation FD disclosure
    Form8-K
  • Aug 26, 2026Filing
    FormD
  • Aug 18, 2026Unregistered sale of shares
    Form8-K
  • Aug 17, 2026Regulation FD disclosure
    Form8-K
  • Aug 12, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Aug 12, 2026Results of operations
    Form8-K
  • Jul 28, 2026Regulation FD disclosure
    Form8-K
  • Jul 7, 2026Regulation FD disclosure
    Form8-K
  • Jun 3, 2026Regulation FD disclosure
    Form8-K
  • Jun 1, 2026Regulation FD disclosure
    Form8-K
  • May 27, 2026Regulation FD disclosure
    Form8-K
  • May 19, 2026Regulation FD disclosure
    Form8-K
  • May 18, 2026Regulation FD disclosure
    Form8-K
  • May 13, 2026Filing
    FormC-TR

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since May 22, 2024.

The full analysis

What do Turn Therapeutics's filings show?

The filings are where every one of Turn Therapeutics's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.